HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype

Journal of Neuroimmunology

Volumn 167, Issue 1-2, 2005, Pages 108-119

  Prat, Elisabetta ^a   Tomaru, Utano ^a   Sabater, Lidia ^b   Park, Deric M ^a   Granger, Rebekah ^a   Kruse, Niels ^c   Ohayon, Joan M ^a   Bettinotti, Maria P ^d   Martin, Roland ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antigen presenting cells; Antigen presenting molecules; MHC; Multiple sclerosis

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR15 ANTIGEN; HLA DR2 ANTIGEN; HLA DR2A ANTIGEN; HLA DR2B ANTIGEN; HLA DRB5 ANTIGEN; INTERLEUKIN 4; UNCLASSIFIED DRUG; BETA INTERFERON; HLA DR15; HLA DRB1*1501, HUMAN; HLA DRB5; HLA-DR15; HLA-DRB1*1501, HUMAN; HLA-DRB5; MESSENGER RNA;

ALLELE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BETA CHAIN; CAUCASIAN; CELL SURFACE; CELL TYPE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS; TISSUE DISTRIBUTION; CELL CULTURE; CLASSIFICATION; COMPARATIVE STUDY; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; LYMPHOCYTE; METABOLISM; METHODOLOGY; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; INTERFERON-BETA; LYMPHOCYTES; MALE; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; THYMUS GLAND; TRANSFECTION;

EID: 24144492777     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.04.027     Document Type: Article

References (38)

1. M. Albis-Camps, and R. Blasczyk Fluorotyping of HLA-DRB by sequence-specific priming and fluorogenic probing Tissue Antigens 53 1999 301 307
2. AppliedBiosystem ABI PRISM 7700 Sequence Detection System. User's Manual 1998 D.20 D.21
3. H. Baum Mitochondrial antigens, molecular mimicry and autoimmune disease Biochim. Biophys. Acta 1271 1995 111 121
4. J. Berdoz, J. Gorski, A. Termijtelen, J. Dayer, C. Irle, D. Schendel, and B. Mach Constitutive and induced expression of the individual HLA-DR β and α chain loci in different cell types J. Immunol. 139 1987 1336 1341
5. R. Bontrop, T. Ottenhoff, R. Van Miltenburg, D. Elferink, R. De Vries, and M. Giphart Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity Eur. J. immunol. 16 1986 133 138
6. R. Brock, K.H. Wiesmüller, G. Jung, and P. Walden Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor Proc. Natl. Acad. Sci. U. S. A. 93 1996 13108 13113
7. I.I.S. Caplen, S. Salvadori, B. Gansbacher, and K.S. Zier Post-transcriptional regulation of MHC class II expression in human T cells Cell. Immunol. 139 1992 98 107
8. S.L. Constant, and K. Bottomly Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches Annu. Rev. Immunol. 15 1997 297 322
9. T. Cotner, H. Charbonneau, E. Mellins, and D. Pious mRNA abundance, rather than differences in subunit assembly, determine expression of HLA-DRβ1 and DRβ3 molecules J. Biol. Chem. 264 1996 11107 11111
10. G. Czerwony, R. Alten, E. Gromnica-Ihle, D. Hagemann, U. Reuter, H. Sorensen, and B. Muller Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals Hum. Immunol. 60 1999 1 9
11. G. Del Pozzo, M. Ciullo, and J. Guardiola Regulation of HLA class II gene expression: the case for posttranscriptional control levels Microbes Infect. 1 1999 943 948
12. D.A. Dyment, G.C. Ebers, and A.D. Sadovnick Genetics of multiple sclerosis Lancet Neurol. 3 2004 104 110
13. P. Emery, B. Mach, and W. Reith The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence Hum. Immunol. 38 1993 137 147
14. D. Fertsch, D.R. Schoenberg, R.N. Germain, J.Y.L. Tou, and S.N. Vogel Induction of macrophage Ia antigen expression by rIFN-γ and down-regulation by IFN-α/β and dexamethasone are mediated by changes in steady-state levels of Ia mRNA J. Immunol. 139 1987 244 249
15. K. Inaba, M. Kitaura, T. Kato, Y. Watanabe, Y. Kawade, and S. Muramatsu Contrasting effect of α/β and γ-interferons on expression of macrophage Ia antigens J. Exp. Med. 163 1986 1030 1035
16. D. Jaraquemada, R. Martin, S. Rosen-Bronson, M. Flerlage, H.F. McFarland, and E.O. Long HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals J. Immunol. 145 1990 2880 2885
17. H. Jiang, R. Milo, P. Swoveland, K.P. Johnson, H. Panitch, and S. Dhib-Jalbut Interferon β-1b reduces interferon γ-induced antigen-presenting capacity of human glial and B cells J. Neuroimmunol. 61 1995 17 25
18. M. Krogsgaard, K.W. Wucherpfennig, B. Cannella, B.E. Hansen, A. Svejgaard, J. Pyrdol, H. Ditzel, C.S. Raine, J. Engberg, and L. Fugger Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex J. Exp. Med. 191 2000 1395 1412
19. N. Kruse, M. Pette, K. Toyka, and P. Rieckmann Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood J. Immunol. Methods 210 1997 195 203
20. H.L.E. Lang, H. Jacobsen, S. Ikemizu, C. Andersson, K. Harlos, L. Madsen, P. Hjorth, L. Sondergaard, A. Svejgaard, K. Wucherpfennig, D.I. Stuart, J.I. Bell, E.Y. Jones, and L. Fugger A functional and structural basis for TCR cross-reactivity in multiple sclerosis Nat. Immunol. 3 2002 940 943
21. P. Louis, R. Vincent, P. Cavadore, J. Clot, and J. Eliaou Differential transcriptional activities of HLA-DR genes in the various haplotypes J. Immunol. 153 1994 5059 5067
22. R. Martin, M.D. Howell, D. Jaraquemada, M. Flerlage, J. Richert, S. Brostoff, E.O. Long, D.E. McFarlin, and H.F. McFarland A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis J. Exp. Med. 173 1991 19 24
23. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu. Rev. Immunol. 10 1992 153 187
24. L.A. Matis, L.H. Glimcher, W.E. Paul, and R.H. Schwartz Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules Proc. Natl. Acad. Sci. U. S. A. 80 1983 6019
25. G.G. Nepom, and H. Erlich MHC class-II molecules and autoimmunity Annu. Rev. Immunol. 9 1991 493 526
26. G.T. Nepom, and W.W. Kwok Molecular basis for HLA-DQ associations with IDDM Diabetes 47 1998 1177 1184
27. K. Ota, M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis Nature 346 1990 183 187
28. M. Pette, K. Fujita, D. Wilkinson, D.M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J.T. Epplen, L. Kappos, and H. Wekerle Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors Proc. Natl. Acad. Sci. U. S. A. 87 1990 7968 7972
29. M.A. Player, K.C. Barracchini, T.B. Simonis, L. Rivoltini, F. Arienti, C. Castelli, A. Mazzocchi, F. Belli, G. Parmiani, and F.M. Marincola Differences in frequency distribution of HLA-A2 sub-types between American and Italian Caucasian melanoma patients: relevance for epitope specific vaccination protocols J. Immunother. 19 1996 357 363
30. W.M. Ridgway, and C.G. Fathman The association of MHC with autoimmune disease: understanding the pathogenesis of autoimmune diabetes Clin. Immunol. Immunopathol. 86 1998 3 10
31. S. Sawcer, M. Maranian, E. Setakis, V. Curwen, E. Akesson, A. Hensiek, F. Coraddu, R. Roxburgh, D. Sawcer, J. Gray, J. Deans, P.N. Goodfellow, N. Walker, D. Clayton, and A. Compston A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility Brain 125 2002 1337 1347
32. L. Stunz, R.W. Karr, and R. Anderson HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level J. Immunol. 143 1989 3081 3086
33. B. Thurner, C. Roder, D. Dieckmann, M. Heuer, M. Kruse, A. Glaser, P. Keikavoussi, E. Kampgen, A. Bender, and G. Schuler Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application J. Immunol. Methods 223 1999 1 5
34. F. Vartdal, L.M. Sollid, B. Vandvik, G. Markussen, and E. Thorsby Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences Hum. Immunol. 25 1989 103 110
35. M. Vergelli, B. Hemmer, P. Muraro, L. Tranquill, W.E. Biddison, A. Sarin, H.F. McFarland, and R. Martin Human autoreactive CD4+ T cell clones use perforin- or Fas-Fas-ligand-mediated pathways for target cell lysis c 158 1997 2756 2761
36. M. Vergelli, M. Kalbus, S.C. Rojo, B. Hemmer, H. Kalbacher, L. Tranquill, H. Beck, H.F. McFarland, R. De Mars, E.O. Long, and R. Martin T cell response to myelin basic protein in the context of the multiple sclerosis associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells J. Neuroimmunol. 77 1997 195 203
37. A. Wandstrat, and E. Wakeland The genetic of complex autoimmune diseases: non-MHC susceptibility genes Nat. Immunol. 2 2001 802 809
38. R. Zhao, D.J. Loftus, E. Appella, and E.J. Collins Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry J. Exp. Med. 189 1999 359 370